GGHC
ETNB

Gilder Gagnon Howe & Co’s 89bio ETNB Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,968
Closed -$145K – 244
2025
Q1 		$145K Buy
+19,968
New +$175K ﹤0.01% 230
2023
Q4 		– Sell
-81,207
Closed -$1.25M – 260
2023
Q3 		$1.25M Buy
81,207
+244
+0.3% +$4.1K 0.02% 201
2023
Q2 		$1.53M Buy
80,963
+4,960
+7% +$87.1K 0.02% 208
2023
Q1 		$1.16M Buy
76,003
+26,126
+52% +$341K 0.02% 194
2022
Q4 		$635K Buy
+49,877
New +$449K 0.01% 206
2021
Q2 		– Sell
-30,916
Closed -$732K – 418
2021
Q1 		$732K Sell
30,916
-983
-3% -$22.7K ﹤0.01% 310
2020
Q4 		$777K Sell
31,899
-349
-1% -$8.92K ﹤0.01% 277
2020
Q3 		$827K Buy
+32,248
New +$1.02M 0.01% 266

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gilder Gagnon Howe & Co's ETNB Position: Q2 2025 in Review

Gilder Gagnon Howe & Co sold out of 89bio (ETNB) in Q2 2025, closing a stake of 19,968 shares — an estimated $145K sold.

Gilder Gagnon Howe & Co first reported a position in ETNB in Q3 2020 and held it in 8 quarters. The position peaked at $1.53M in Q2 2023. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Gilder Gagnon Howe & Co reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 19,968 89bio shares in Q2 2025, an estimated $145K.
  • Gilder Gagnon Howe & Co first reported a position in 89bio in Q3 2020 and held it in 8 quarters.
  • Gilder Gagnon Howe & Co's 89bio position peaked at $1.53M in Q2 2023.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2025, filed 14 Aug 2025.